Acknowledgments The authors would like to acknowledge Dr. James Zangrilli and Dr. Alex de Giorgio-Miller for their instrumental contributions to the study concept, Mr. Joash Tan (BSc, Hons) of the Observational and Pragmatic Research Institute (OPRI), for editorial and formatting assistance that supported the development of this publication Funding This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.Peer reviewedPublisher PD
U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical companies an...
Acknowledgments The authors would like to thank Hilary Pinnock, Nemr Eid, Randal Brown, Miguel Román...
Severe asthma is an important topic in respiratory diseases, due to its high impact on morbidity and...
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte L...
Funding: This research study was funded and delivered by the Observational & Pragmatic Research Inst...
FUNDING/SUPPORT: This study was conducted by the Observational and Pragmatic Research Institute (OPR...
Background: Many severe asthma patients with high oral corticosteroid exposure (HOCS) often do not i...
This study is cofunded by Optimum Patient Care Global and AstraZeneca.Peer reviewedPostprin
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
Inflammation, structural and functional abnormalities within the airways are key features of asthma....
Funding Information: The SHARP National Leads survey revealed that corticosteroid-induced toxicity w...
Background: Effectiveness of biologics has neither been established in patients with high oral corti...
Acknowledgements: We thank the data input and medical staff in the UK Difficult Asthma Centres. Fund...
Acknowledgements The iHARP database was funded by unrestricted grants from Mundipharma International...
Acknowledgements We would like to acknowledge Dr. Ghislaine Scelo (PhD) and Dr. Nasloon Ali (PhD) of...
U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical companies an...
Acknowledgments The authors would like to thank Hilary Pinnock, Nemr Eid, Randal Brown, Miguel Román...
Severe asthma is an important topic in respiratory diseases, due to its high impact on morbidity and...
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte L...
Funding: This research study was funded and delivered by the Observational & Pragmatic Research Inst...
FUNDING/SUPPORT: This study was conducted by the Observational and Pragmatic Research Institute (OPR...
Background: Many severe asthma patients with high oral corticosteroid exposure (HOCS) often do not i...
This study is cofunded by Optimum Patient Care Global and AstraZeneca.Peer reviewedPostprin
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
Inflammation, structural and functional abnormalities within the airways are key features of asthma....
Funding Information: The SHARP National Leads survey revealed that corticosteroid-induced toxicity w...
Background: Effectiveness of biologics has neither been established in patients with high oral corti...
Acknowledgements: We thank the data input and medical staff in the UK Difficult Asthma Centres. Fund...
Acknowledgements The iHARP database was funded by unrestricted grants from Mundipharma International...
Acknowledgements We would like to acknowledge Dr. Ghislaine Scelo (PhD) and Dr. Nasloon Ali (PhD) of...
U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical companies an...
Acknowledgments The authors would like to thank Hilary Pinnock, Nemr Eid, Randal Brown, Miguel Román...
Severe asthma is an important topic in respiratory diseases, due to its high impact on morbidity and...